Of all the healthcare policies the government blasted out over the summer, one should have stood out for pharma. The NHS is edging towards one of the most radical reforms in its history: the creation ...
Despite bold ambitions in the Life Sciences Vision and NHS 10-Year Plan, uptake of new medicines remains slow. Can industry, ...
AI is already playing a fundamental role in every stage of the drug discovery process – from ideation all the way through to ...
Dr John Snowden, Consultant Haematologist and Director of Blood and Marrow Transplant at Sheffield Teaching Hospitals, said: ...
Although many of the terms in a ‘nurse’ word cloud may hint at the broad job description (care, diligence, compassion etc), I ...
AC Immune SA has announced peer-reviewed results from its phase 1b/2a trial of two Tau-targeting active immunotherapies for early Alzheimer’s disease. The study compared ACI-35.030, developed with AC ...
As an occupation at the very epicentre of healthcare, the nurse is a constant and iconic presence. In this edition of ...
Xeltis has announced successful results from its aXess EU phase 3 trial, confirming the potential of its restorative vascular ...
Acella Pharmaceuticals and Neuvosyn Laboratories have announced positive topline results from a phase 2 clinical trial of ...
Three new studies have launched in Manchester to evaluate the effectiveness of vaccines for severe acute respiratory ...
Tezspire (tezepelumab) has received a positive opinion from the CHMP for the treatment of chronic rhinosinusitis with nasal ...
Johnson & Johnson has announced a positive opinion from the CHMP recommending expanded marketing authorisation for TREMFYA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results